Covid-19 has provided the impetus and catalyst for further acceleration in the growth of pharmaceutical industries, leading to high-risk pollutions across the world.
In MOH’s new Braille pharmaceutical packaging initiative that will be launched at 250 Klinik Kesihatan nationwide, the Braille format for the blind only includes the drug dosage and indication, while the name of the medicine remains in standard writing.
APHM and PhAMA indicate possible medicine price hikes due to “significant” increases in the cost of logistics, active pharmaceutical ingredients (APIs), and labour.
Dr Kelvin Yii tells NPRA to extensively audit pharmaceutical stock across public and private facilities, adding that health care providers should start rationing medicines now.
Private hospitals say life-saving treatments and medicines for critical illnesses are still available for now, including cardiovascular and cancer drugs.
The National Pharmaceutical Regulatory Agency asked local pharmaceutical suppliers and manufacturers, as well as multinational pharmaceutical companies, to help address the medicine supply problem.
Malaysian pharmaceutical suppliers expect worsening shortages not only of OTC drugs, but medicines across all therapeutic segments in the mid- to long-term.